Literature DB >> 11822782

Low molecular weight heparin inhibits tumor necrosis factor alpha-induced leukocyte rolling.

M X Wan1, X W Zhang, L Törkvist, H Thorlacius.   

Abstract

OBJECTIVE: Heparins may exert several anti-inflammatory actions. This study investigated the impact of low molecular weight heparin (LMWH) on tumor necrosis factor (TNF)-alpha-provoked leukocyte rolling, adhesion and extravascular accumulation.
MATERIALS AND METHODS: Leukocyte-endothelium interactions and tissue accumulation of leukocytes were induced by TNF-alpha in Balb/c mice and analyzed by the use of intravital microscopy in the mouse cremaster muscle microcirculation.
RESULTS: We observed that administration of 5000 units/kg of LMWH, but not 50 and 500 units/kg, markedly reduced TNF-alpha-induced leukocyte rolling, adhesion and tissue infiltration. Notably, when LMWH was given after TNF-alpha only leukocyte rolling was reduced and no effect was observed on firm adhesion of leukocytes.
CONCLUSIONS: Taken together, these findings indicate that LMWH inhibits TNF-alpha-induced leukocyte accumulation by inhibiting the rolling adhesive interaction which may help explain the anti-inflammatory effects of LMWH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11822782     DOI: 10.1007/PL00000237

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  10 in total

1.  Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin.

Authors:  Herbert H Lipowsky; Anne Lescanic
Journal:  Microvasc Res       Date:  2017-03-27       Impact factor: 3.514

Review 2.  The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies.

Authors:  Brooke L Farrugia; Megan S Lord; James Melrose; John M Whitelock
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

3.  Tumor necrosis factor alpha and macrophages in the brain of herpes simplex virus type 1-infected BALB/c mice.

Authors:  Mark Fields; Mei Zheng; Ming Zhang; Sally S Atherton
Journal:  J Neurovirol       Date:  2006-12       Impact factor: 2.643

4.  The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model.

Authors:  I Debergh; N Van Damme; P Pattyn; M Peeters; W P Ceelen
Journal:  Br J Cancer       Date:  2010-02-02       Impact factor: 7.640

5.  Prophylactic Low Molecular Weight Heparin Improving Perinatal Outcome in Non-thrombophilic Placental-Mediated Complications.

Authors:  Shweta Singh; Renuka Sinha; Mayank Kaushik
Journal:  J Obstet Gynaecol India       Date:  2015-07-09

6.  Uniocular anterior chamber inoculation of a tumor necrosis factor alpha-expressing recombinant of herpes simplex virus type 1 results in more rapid destruction and increased viral replication in the retina of the uninoculated eye.

Authors:  Mark A Fields; Mei Zheng; Pam Wall; Scott Oberg; Sally S Atherton
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

Review 7.  The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19.

Authors:  Heloísa Antoniella Braz-de-Melo; Sara Socorro Faria; Gabriel Pasquarelli-do-Nascimento; Igor de Oliveira Santos; Gary P Kobinger; Kelly Grace Magalhães
Journal:  Front Med (Lausanne)       Date:  2021-04-23

8.  Effects of low molecular weight heparin on the polarization and cytokine profile of macrophages and T helper cells in vitro.

Authors:  Valentina Bruno; Judit Svensson-Arvelund; Marie Rubér; Göran Berg; Emilio Piccione; Maria C Jenmalm; Jan Ernerudh
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

9.  Dual-function injectable angiogenic biomaterial for the repair of brain tissue following stroke.

Authors:  Lina R Nih; Shiva Gojgini; S Thomas Carmichael; Tatiana Segura
Journal:  Nat Mater       Date:  2018-05-21       Impact factor: 43.841

10.  Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host.

Authors:  M Ursula Norman; Tara J Moriarty; Ashley R Dresser; Brandie Millen; Paul Kubes; George Chaconas
Journal:  PLoS Pathog       Date:  2008-10-03       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.